Chaptern 1.n Then Rolen ofn then NursenPractitio
nernMultiplen Choice
Identifyn then choicen thatn bestn completesn then statementn orn answersn then question.
n nnn 1.n Nursen practitionern prescriptiven authorityn isn regulated by:
1. Then Nationaln Counciln ofn Staten Boardsn ofnnnNursing
2. Then U.S.n Drugn Enforcementn Administration
3. Then Staten Boardn ofn Nursingn forn eachn state
4. Then Staten Boardn ofn Pharmacy
nnnnnnnnn 2.nThen benefitsn ton then patientn ofn havingn ann Advancedn Practicen Registeredn Nursen(APRN)
n prescribern include:
1. Nursesn known moren aboutn Pharmacologyn thann othernnnprescribersnnnbecausenthey
ntakenitnbothninntheirn basicn nursingn programnvandn inn theirn APRNnprogram.
2. Nursesn caren forn then patientn fromn an holisticnvapproachn andn includenthe
n patientninn decisionn makingn regardingnvtheirn care.
3. APRNsn aren lessn likelyn ton prescribenvnarcoticsn andn othern controlledn substances.
4. APRNsn aren ablen ton prescriben independentlyn inn alln states,n whereasn an physician’snassistan
tn needsn ton haven an physiciannvsupervisingn theirn practice.
n 3. Clinicaln judgmentn inn prescribing includes:
1. Factoringn inn then costn tonvthenvpatientn ofn then medicationn prescribed
2. Alwaysn prescribingn thenvnewestn medicationn availablen forn then diseasen process
3. Handingn outn drugnvsamplesn ton poorn patients
4. Prescribingn allnvgenericnvmedicationsn ton cutn costs
n
4. Criterian forn choosingnvann effectiven drugn forn an disordern include:
1. Askingn thenvpatientn whatn drugn theyn thinkn wouldn workn bestn forn them
2. Consultingnvnationallyn recognizedn guidelinesn forn diseasen management
3. Prescribingnvmedicationsn thatn aren availablen asn samplesn beforen writingn an prescription
4. Followingn U.S.n Drugn Enforcementn Administrationn guidelinesn forn prescribing
n
5. Nursenvpractitionern practicen mayn thriven undern health-caren reformn becausen of:
1.n Thenvdemonstratedn abilityn ofn nursen practitionersn ton controln costsn andnvimprove
n patientn outcomes
2. Then factn thatn nursen practitionersn willn ben ablen ton practicen independently
3. Thenfactnthatnnursenpractitionersnwillnhavenfullnreimbursementn undernhealth-
carenreform
4. Then abilityn ton shiftn accountabilityn forn Medicaidn ton then staten level
,
,Chaptern1.nThenRolenofnthenNursenPractitioner
nAnswern Section
MULTIPLEn CHOICE
1.nANS: 3 PTS: 1
2.nANS: 2 PTS: 1
3.nANS: 1 PTS: 1
4.nANS: 2 PTS: 1
5.nANS: 1 PTS: 1
Chaptern 2.n Reviewn ofn Basicn Principlesn of
PharmacologynMultiplen Choice
Identifyn then choicen thatn bestn completesn then statementn orn answersn thenvquestion.
n
nnn 1.n An patient’sn nutritionaln intaken andn laboratorynvresultsnvreflectn hypoalbuminemia.n Thisn isncritic
alnto
prescribingn because:
1. Distributionn ofn drugsn ton targetn tissuen maynvben affected.
2. Then solubilityn ofn then drugn willn notnvmatchnnnthen siten ofn absorption.
3. Theren willn ben lessn freen drugn availablen ton generaten ann effect.
4. Drugsn boundn ton albuminn aren readilynvexcretedn byn then kidneys.
n nnn 2.n Drugsn thatn haven an significantnvfirst-pass effect:
1. Mustn ben givenn byn thenventeralnv(oral)n routennnonly
2. Bypassn then hepaticn circulation
3. Aren rapidlyn metabolizednvbyn then livern andn mayn haven littlen ifn anyn desiredn action
4. Aren convertednvbynvthenvlivern ton moren activen andn fat-solublen forms
n nnn 3.n Then routen ofn excretionn ofn an volatilen drugn willnnnlikelyn be the:
1. Kidneys
2. Lungs
3. Bilenvandn feces
4. Skin
n
4.n Medroxyprogesteronen (Depon Provera)n isn prescribedn intramuscularlyn (I
nnn
M)n toncreaten an storagen reservoirn ofn then drug.n Storagen reservoirs:
1. Assuren thatn then drugn willn reachn itsn intendedn targetn tissue
2. Aren then reasonn forn givingn loadingn doses
3. Increasen then lengthn ofn timen an drugn isn availablen andn active
4. Aren mostn commonn inn collagenn tissues
n nnn 5.n Then NPn choosesn ton given cephalexinn everyn 8n hoursn basedn onnnnknowledgen ofn thennn drug’s:
1. Propensityn ton gon ton then targetn receptor
2. Biologicaln half-life
3. Pharmacodynamics
4. Safetyn andn siden effects
, n
nnn 6.n Azithromycinn dosingn requiresn thatn then firstn day’sn dosagen ben twicen thosen ofn then othern 4nda
ysn ofn the
prescription.n Thisn isn consideredn an loadingn dose.n An loadingn dose:
1. Rapidlyn achievesn drugn levelsn inn then therapeuticn range
2. Requiresn four-n ton five-half-livesn ton attain
3. Isn influencedn byn renaln function
4. Isn directlyn relatedn ton then drugn circulatingn ton then targetn tissues
n nnn 7.n Then pointn inn timen onn then drugn concentrationn curven thatn indicatesn then firstn signn of
an therapeuticn effectnisn the:
1. Minimumn adversen effectn level
2. Peakn ofn action